Avid Bioservices Profit Margin

The latest profit margin for CDMO is -101.07% as of October 2024. That compares with -8.12% in the prior-year period — down 1144.0% year over year. That is below the Healthcare sector average of 14.34%. Investors often review this figure alongside Avid Bioservices's historical trend and sector peers before judging valuation or financial health.

Over the past year, CDMO's profit margin moved from -8.12% to -101.07% — a 1144.0% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Avid Bioservices's valuation or profitability profile.

Against Healthcare companies, CDMO currently prints -101.07% for profit margin, while the sector average sits near 14.34%. That is roughly 804.6% below the sector mean. Large gaps often invite a closer look at Avid Bioservices's growth, margins, and balance sheet.

Profit Margin shows how effectively Avid Bioservices converts resources into returns. At -101.07%, CDMO may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with -8.12% in the prior-year period — down 1144.0% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting CDMO's profit margin (-101.07%), review year-over-year change from -8.12%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.